$200.85
+2.8%Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience. Welltower, a real estate investment trust (REIT), owns interests in properties concentrated in major, high-growth markets in the United States, Canada and the United Kingdom, consisting of seniors housing and post-acute communities and outpatient medical properties.
Wall Street analysts project that WELL stock may rise significantly over the coming 12 months. The consensus 1-year price target stands at 239.11, with estimates ranging from a low of 215.00 to a high of 249.00.
The consensus 1-year price target stands at 239.11, with estimates ranging from a low of 215.00 to a high of 249.00.
Strong upside potential. Consensus indicates attractive return opportunity with favorable risk-reward profile.
High analyst agreement. Narrow target range indicates strong consensus on valuation, suggesting clear investment thesis and predictable outlook.
Strong buy conviction: High upside with tight consensus suggests compelling investment opportunity backed by analyst confidence.
Monitor and evaluate: Current analyst consensus suggests limited conviction or near-term catalysts. Stay informed on company developments and reassess positioning as new information emerges.
Solid growth trajectory indicates healthy business performance and competitive positioning.
Moderate coverageโsufficient for guidance but may lack depth of large-cap analysis.
Moderate uncertainty in forecastsโtypical for companies with evolving business models.
Generally favorable outlook with reasonable growth prospects and analyst support.
Strong growth expectations signal robust business momentum and market opportunity expansion.
Moderate coverageโsufficient for guidance but may lack depth of large-cap analysis.
Reasonable estimate spread indicates general agreement with normal forecast variance.
Positive analyst consensus with strong growth expectations and forecast confidence.
Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.
Strong growth expectations signal robust business momentum and market opportunity expansion.
Moderate coverageโsufficient for guidance but may lack depth of large-cap analysis.
Reasonable estimate spread indicates general agreement with normal forecast variance.
Positive analyst consensus with strong growth expectations and forecast confidence.
Compelling growth story with analyst consensus: Strong projected growth combined with narrow estimate spread suggests high-conviction opportunity.
Strong growth expectations signal robust business momentum and market opportunity expansion.
Moderate coverageโsufficient for guidance but may lack depth of large-cap analysis.
Moderate uncertainty in forecastsโtypical for companies with evolving business models.
Generally favorable outlook with reasonable growth prospects and analyst support.
Strong growth expectations signal robust business momentum and market opportunity expansion.
Moderate coverageโsufficient for guidance but may lack depth of large-cap analysis.
Moderate uncertainty in forecastsโtypical for companies with evolving business models.
Generally favorable outlook with reasonable growth prospects and analyst support.
Significant contraction projectedโmajor business challenges or industry disruption likely.
Moderate coverageโsufficient for guidance but may lack depth of large-cap analysis.
Moderate uncertainty in forecastsโtypical for companies with evolving business models.
Mixed signalsโsome positive indicators offset by concerns about growth or uncertainty.
During the last 12 months, insiders have purchased $1.51M and sold $19.25M worth of WELL shares, resulting in $17.74M of net selling activity.
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
0
0.00
0
0.00
+0
+$0
10.0K
1.51M
126.3K
19.25M
-17.7M
-$17.74M
Gundlach Andrew
Director
$1.51M
Mitra Shankh
Director, Officer: Ceo
$13.15M
Mchugh Timothy
Officer: Co-President And Cfo
$2.00M
Chaudhri Nikhil
Officer: Co-President And Cio
$1.41M
Mcqueen Matthew Grant
Officer: Chief Legal Officer
$1.35M
Burkart John F.
Officer: Vice Chairman And Coo
$1.35M
Strong bearish signal with $17.74M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
5 insider sellers vs. 1 buyers. Widespread selling across multiple insiders may signal concerns.
Continue your WELL research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.